Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-23

Clinical Trial Update: Efficacy of Dietary Supplementation With Lactobacilllus Reuteri DSM 17938 on Functional Abdominal Pain (FAP) in Children [NA]

View source ↗

Summary

This clinical trial evaluated the probiotic Lactobacillus reuteri DSM 17938 for functional abdominal pain in children. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Aghia Sophia Children's Hospital of Athens | Conditions: Functional Abdominal Pain (FAP) in Children | NA | Status: COMPLETED